| Cardiovascular Risk Management |
1 |
1 |
| Biologic Therapy |
0 |
0.72 |
| Antioxidant |
0 |
0.99 |
| Hypertension |
0 |
0.52 |
| Meta-Analysis |
0 |
0.51 |
| Fatty Acids |
0 |
0.4 |
| Heart Failure (HF) |
0 |
0.38 |
| Cerebrovascular Accident |
0 |
0.3 |
| Coronary Artery Disease (CAD) |
0 |
0.24 |
| Heart |
0 |
0.23 |
| Hospital |
0 |
0.23 |
| Vitamin |
0 |
0.23 |
| Healthcare and Medical Technology |
0 |
0.2 |
| Patient Safety |
0 |
0.2 |
| Nutrition |
0 |
0.17 |
| Myocardial Infarction (MI) |
0 |
0.16 |
| Pulmonary Arterial Hypertension |
0 |
0.14 |
| Obesity |
0 |
0.12 |
| Board Certification |
0 |
0.11 |
| Clinical Research |
0 |
0.11 |
| Social Determinants of Health |
0 |
0.07 |
| Adverse Effects |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Cardiovascular disease |
0 |
0.06 |
| Diet |
0 |
0.06 |
| Diversity |
0 |
0.06 |
| Epidemiology |
0 |
0.06 |
| Infarction |
0 |
0.06 |
| Massachusetts |
0 |
0.06 |
| Medical Innovations |
0 |
0.06 |
| Minerals |
0 |
0.06 |
| Preventive Medicine |
0 |
0.06 |
| Pulmonary Hypertension |
0 |
0.06 |
| Stroke Risk |
0 |
0.06 |
| Surgery |
0 |
0.06 |